The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...

With 103 lung transplants and one heart-lung transplant in 2024, MHH is the leader in the Eurotransplant network. The lung transplant team relies on minimally invasive procedures and innovative ...

Cardiac and pulmonary wellness dietitian Sheri Gaw tells Yahoo LIfe that “salt alternatives are especially helpful for people ...

Q3 2025 Earnings Call Transcript February 10, 2025 Beyond Air, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.24. Operator: Good afternoon, and welcome everyone to the ...

However, analysts project potential upside of 92% in 2025, according to the Street-high estimate.  Investors should also note that Merck pays a dividend yielding 3.71%, more than twice the healthcare ...

Your kidneys are working tirelessly throughout the day to keep your system clean from unwanted waste products and fluids.

Bayer will present new data from its prostate cancer portfolio at the upcoming American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place in San Francisco, ...

DelveInsight’s, “HDAC Inhibitor Pipeline Insight” report provides comprehensive insights about 40+ companies and 50+ pipeline ...

What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.

Stifel raised the firm’s price target on Insmed (INSM) to $97 from $88 and keeps a Buy rating on the shares. While acknowledging M&A ...